Pharmaceuticals and Medical Research (TRBC)
What do studies on new coronavirus mutations tell us?
LONDON (Reuters) – A series of studies of the genomes of thousands of samples of the new coronavirus SARS-CoV-2 show that it is mutating and evolving as it adapts to its human hosts. FILE PHOTO: The ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV), which was identified as the cause of an outbreak of …
Novartis plans Zolgensma giveaways as some fear ‘health lottery’
ZURICH (Reuters) – Novartis aims to give away 100 doses of its $2.1 million-per-patient Zolgensma for spinal muscular atrophy (SMA) in 2020 in a free-drug program that one patient group worried was a “health lottery” that could neglect some babies. FILE PHOTO: The company’s logo is seen at the new cell and gene therapy factory …
Jeff Bezos sells Amazon stock worth $2.8 billion last week
FILE PHOTO – Jeff Bezos, founder of Amazon and Blue Origin speaks during the JFK Space Summit, celebrating the 50th anniversary of the moon landing, at the John F. Kennedy Library in Boston, Massachusetts, U.S., June 19, 2019. REUTERS/Katherine Taylor (Reuters) – Amazon.com Inc (AMZN.O) Chief Executive Officer Jeff Bezos offloaded $990 million worth of …
Co-owner, ex-employee of pharmacy in U.S. meningitis outbreak acquitted
BOSTON (Reuters) – A federal judge on Friday tossed the convictions of a co-owner and former employee of a Massachusetts compounding pharmacy accused of conspiring to help it evade regulatory oversight before its drugs caused a deadly 2012 fungal meningitis outbreak. FILE PHOTO: Gregory Conigliaro, a co-owner of the now-defunct New England Compounding Center, enters …
